Balance Sheet
| Symbiotec Pharmalab Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
544889
ISIN Demat:
INE899I01028
Book Value(₹): 195.23 NSE Symbol:
SYMBIOTEC
Div & Yield(%):
N.A
Market Cap(₹ Cr): 7,935.95 P/E(TTM):
50.91
EPS(TTM):
24.26
Face Value(₹): 2.00 |
| Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | Dec 21 (₹ Cr) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 10.94 | 10.94 | 10.94 | 10.94 | 10.94 |
| Reserves | 899.85 | 750.20 | 661.88 | 684.25 | 622.42 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 910.79 | 761.14 | 672.82 | 695.19 | 633.36 |
| Secured Loans | 292.52 | 51.72 | 107.27 | 63.59 | 47.42 |
| Unsecured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt | 292.52 | 51.72 | 107.27 | 63.59 | 47.42 |
| Other Liabilities | 15.41 | 12.36 | 7.13 | 6.67 | 5.99 |
| Total Liabilities | 1,218.72 | 825.22 | 787.22 | 765.45 | 686.77 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 544.84 | 513.66 | 418.24 | 391.57 | 348.52 |
| Less: Accumulated Depreciation | 227.77 | 189.84 | 152.59 | 125.49 | 100.94 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 317.07 | 323.82 | 265.65 | 266.08 | 247.58 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 59.05 | 19.36 | 73.90 | 22.62 | 26.73 |
| Investments | 44.20 | 42.25 | 65.60 | 130.17 | 122.59 |
| Current Assets, Loans & Advances | |||||
| Inventories | 254.03 | 332.61 | 241.72 | 245.41 | 225.26 |
| Sundry Debtors | 175.98 | 125.43 | 112.31 | 143.66 | 118.69 |
| Cash and Bank Balance | 22.59 | 6.27 | 2.83 | 6.32 | 41.14 |
| Loans and Advances | 26.63 | 33.98 | 29.76 | 20.24 | 26.94 |
| Total Current Assets | 479.23 | 498.29 | 386.62 | 415.62 | 412.03 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 96.34 | 244.86 | 102.36 | 103.36 | 127.56 |
| Provisions | 11.98 | 3.20 | 5.97 | 5.94 | 8.03 |
| Total CL & Provisions | 108.32 | 248.07 | 108.33 | 109.30 | 135.59 |
| Net Current Assets | 370.91 | 250.23 | 278.29 | 306.32 | 276.44 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 0.91 | 6.03 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liability | 21.99 | 19.94 | 19.57 | 19.75 | 19.51 |
| Net Deferred Tax | -21.08 | -13.91 | -19.57 | -19.75 | -19.51 |
| Other Assets | 448.58 | 203.47 | 123.35 | 59.99 | 32.95 |
| Total Assets | 1,218.73 | 825.22 | 787.22 | 765.43 | 686.78 |
| Contingent Liabilities | 0.00 | 0.00 | 0.71 | 0.00 | 0.00 |